- Research Article
- 10.4414/cvm.2023.02276
Albrecht von Haller Awards of the Swiss Heart Foundation 2023
- May 17, 2023
- Cardiovascular Medicine
- Thomas Lscher + 2 more +2
Publications from 2021 to 2026
Showing 5 of 5 papers
Albrecht von Haller Awards of the Swiss Heart Foundation 2023
The Swiss Heart Foundation.
Swissheart-Coach – neues Online-Risikomanagement-Programm für Ihre Patienten
Zusammenfassung. Mit dem Swissheart-Coach hat die Schweizerische Herzstiftung eine webbasierte Informationsplattform mit einem kardiovaskulären Risikorechner lanciert. Das absolute Risiko und das Herzalter werden aufgrund bekannter und auch andernorts verwendeter Algorithmen berechnet, wobei die Kriterien Alter, Geschlecht, Vorerkrankungen, systolischer Blutdruck, Nikotinkonsum und Cholesterin berücksichtigt werden. Zusätzlich werden die Anzahl gerauchter Zigaretten, der Energieverbrauch bei körperlicher Aktivität, Ernährungsgewohnheiten und Stress erfragt und gemäss grossen Studien einbezogen. Das relative Risiko wird im Vergleich zu einer Person gleichen Alters und Geschlechts mit optimalem Gesundheitsverhalten ausgewiesen. Die detaillierten Ergebnisse dieser Analyse werden mit anschaulichen Diagrammen in Ampelfarben präsentiert und in einem mehrseitigen Report festgehalten. Die Nutzer haben die Möglichkeit, sich Ziele zu setzen und Veränderungen zu planen. Das Gesundheitspotenzial und die mögliche Risikoreduktion dank einem gesunden Lebensstil werden im Vergleich zur Ausgangslage grafisch dargestellt. Für registrierte Benutzer besteht die Möglichkeit, die Daten gesichert abzuspeichern, einen Längsverlauf zu erstellen und sich Erinnerungsmails senden zu lassen.
Read moreCardiovascular Risk Assessment and Effects on Behavior in Switzerland The Swiss Heart Foundation HerzCheck®/Cardio-Test®
Background: “CardioTest®” is a tool for cardiovascular risk assessment. The aim of this study was to evaluate if this test used in Swiss pharmacies provides risk stratification and if it had impact on individual behaviour.Methods: Individuals were evaluated (blood pressure, body waist circumference, random blood samples and coronary artery disease risk factors). The cardiovascular risk was calculated (AGLA Risk Score (ARS) a modified PROCAM Score) and participants were informed about their result. One year after the initial testing individuals were followed up by questionnaire with respect to the action they had taken based upon the ARS results. The relation between ARS results and events during follow-up were assessed. Events were defined as cardiovascular events due to chest pain, myocardial infarction or stroke.Result: A total of 1415 individuals were contacted for follow-up, 746 (53%) with a mean age of 62.7 (±12.8) years (60% were male) returned their questionnaire. The cardiovascular risk throughout the study-population turned out to be low: 73.9% had a low ARS <10%, 21.7% an intermediate ARS 10-20% and 4.4% had a high ARS >20%. Significantly more participants with ARS >20% consulted their family doctor (46.2%) than those with ARS 10-20% (25.2%) and ARS <10% (10.4%), respectively (p<0,01 for both comparisons). Sixty-four individuals (9%) suffered a cardiovascular event. The event rates increased as a function of ARS.Conclusion: The overall cardiovascular risk of individuals participating in a pharmacy based risk assessment program seems to be low. CardioTest ® provided risk stratification with respect to future cardio-vascular events. CardioTest ® seems to have impact on individual behavior and lifestyle modification. Other settings and locations for screening might be considered to reach higher risk individuals at an earlier stage.
Read moreIncreased central body fat deposition precedes a significant rise in resting blood pressure in male offspring of essential hypertensive parents: a 5 year follow-up study.
As long as offspring of essential hypertensive parents (OHyp) are lean, their blood pressure usually remains within normal limits. The mechanism(s) transforming this 'genetically dysregulated normotension' into hypertension are unclear. We hypothesized that OHyp are not only genetically prone to develop hypertension, but may also have a particular propensity to accumulate central body fat. A 5-year follow-up cohort study. University Hospital in Switzerland. Seventeen young (25 +/- 1 years, mean +/- SD), lean healthy normotensive male OHyp and 17 age- and sex-matched offspring of normotensive parents (ONorm) paired for baseline blood pressure with the OHyp. Resting and exercise blood pressure, body weight, body mass index (BMI) and waist-to-hip ratio were assessed at baseline and after 5 years. At baseline, body weight, BMI, waist-to-hip ratio and blood pressure did not differ significantly between OHyp and ONorm. At follow-up, body weight was increased in both groups (from 73.9 +/- 6.0 to 77.7 +/- 8.1 kg in OHyp, P = 0.008, and from 71.5 +/- 6.9 to 73.5 +/- 6.6 kg in ONorm, P = 0.03). BMI followed a similar pattern. In contrast, waist-to-hip ratio increased in OHyp (from 0.84 +/- 0.03 to 0.87 +/- 0.03, P = 0.012), but not in ONorm (from 0.84 +/- 0.03 to 0.84 +/- 0.04, P = 0.79) and was therefore higher in OHyp at follow-up (P = 0.011, OHyp versus ONorm). Peak systolic blood pressure during dynamic exercise also rose at 5 years in the OHyp (from 182 +/- 10 to 214 +/- 17 mmHg, P = 0.0001) while resting systolic blood pressure only tended to do so (from 121 +/- 7 to 128 +/- 12 mmHg, P = 0.07). In ONorm, resting and peak dynamic exercise systolic blood pressure remained unchanged (119 +/- 11 versus 121 +/- 9 mmHg, baseline versus follow-up, P = 0.40, and 186 +/- 12 versus 196 +/- 22 mmHg, P = 0.10, respectively). Thus, systolic peak exercise blood pressure was significantly (P = 0.014) elevated at follow-up in OHyp compared to ONorm, while resting systolic blood pressure only tended (P = 0.06) to do so. Initially lean normotensive OHyp have a disparate long-term course of central body fat as compared to ONorm. Thus, OHyp are not only genetically prone to develop hypertension, but they also have a particular propensity to accumulate central body fat, even before a distinct rise in resting blood pressure occurs. The exaggerated blood pressure response to exercise observed at follow-up in the OHyp represents another marker that confers them a greater risk of developing future hypertension.
Read more